⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Capitalmind Flexi Cap Fund - Growth - Direct Plan | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | Capitalmind MF | HDFC MF |
| Category | Equity - Flexi Cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹10.02 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Anoop Vijaykumar | Nikhil Mathur |
| Inception | 04 Aug 2025 | 04 Oct 2023 |
| Returns | ||
| 1Y | -1.30% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 0.41% | 29.15% |
| Risk | ||
| 9.34 | 14.07 | |
| 0.60 | 0.59 | |
| -0.38 | 1.59 | |
| 0.80 | 21.67 | |
| -0.60 | 3.48 | |
| -8.33% | -9.23% | |
| Costs | ||
| Expense Ratio | 1.72% | 1.03% |
| Exit Load | 1% on or before 1M, Nil after 1M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹1,000 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Capitalmind MF93%
HDFC MF93%
7.4%Only 7.4% of holdings by weight are common between Capitalmind MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingCapitalmind MFHDFC MF
Divi's Laboratories Ltd.3.90%9.39%
Torrent Pharmaceuticals Ltd.3.47%3.65%
Category context: Equity vs Equity. Open the full Screener →